AIDS: Η πρόληψη πρέπει να ξεκινά από το φαρμακείο
AIDS: Η πρόληψη πρέπει να ξεκινά από το φαρμακείο
EU Approves Two-Drug Pill as First-Line Treatment for HIV
Κάντε like στη σελίδα μας στο facebook για να μαθαίνετε πρώτοι όλα τα νέα!! The two-drug pill Dovato, developed by the UK company ViiV Healthcare, has been approved as … Continue Reading EU Approves Two-Drug Pill as First-Line Treatment for HIV
Research Roundup: Dog Ownership, Diabetes, Alzheimer’s, HIV Vaccine and More
Research Roundup: Dog Ownership, Diabetes, Alzheimer’s, HIV Vaccine and More
Έγκριση συνδυασμού του doravirine κατά του HIV-1
Έγκριση συνδυασμού του doravirine κατά του HIV-1
Gilead Sciences Cuts 150 Sales Jobs After Drugs Lose Patent Protection
Gilead Sciences Cuts 150 Sales Jobs After Drugs Lose Patent Protection
Janssen’s HIV Drug Symtuza Shows Long-Term Effect in Late Stage Trial
Janssen’s HIV Drug Symtuza Shows Long-Term Effect in Late Stage Trial
GSK’s Dovato chalks up first 2-drug regimen nod for new HIV patients, but will doctors use it?
GSK’s Dovato chalks up first 2-drug regimen nod for new HIV patients, but will doctors use it?
J&J and ViiV Healthcare’s 2-Drug Monthly HIV Shots Equal to Daily Pills
J&J and ViiV Healthcare’s 2-Drug Monthly HIV Shots Equal to Daily Pills
Rejuvenating Brain Cells, Curing HIV, and Bacteria That Eat Pollution
Rejuvenating Brain Cells, Curing HIV, and Bacteria That Eat Pollution
7 Diseases CRISPR Technology Could Cure
7 Diseases CRISPR Technology Could Cure
Researchers develop new, more effective method for detection of HIV virus genomes
Researchers develop new, more effective method for detection of HIV virus genomes
Σημαντική ανακάλυψη για τον ιό του AIDS
Σημαντική ανακάλυψη για τον ιό του AIDS
Research Roundup: HIV Vaccine, Super-Accurate Cervical Cancer Test, Molecular Mechanisms of Autism and Schizophrenia
Research Roundup: HIV Vaccine, Super-Accurate Cervical Cancer Test, Molecular Mechanisms of Autism and Schizophrenia
Seven Trends That Shaped 2018
Seven Trends That Shaped 2018
Biktarvy’s success raises doubts about ViiV’s ‘new era’ of HIV treatment
Biktarvy’s success raises doubts about ViiV’s ‘new era’ of HIV treatment
Gilead names Roche veteran O’Day as CEO
Gilead names Roche veteran O’Day as CEO
